The goal of NIAID transplantation research is to improve the long-term success of organ, tissue, and cell transplantation by understanding the role the immune system plays in transplant success or failure. NIAID-supported investigators are working to selectively control or eliminate unwanted immune responses while maintaining the immune system's ability to fight infection and cancer. The aim is to modify the immune response in a way that will improve long-term transplant survival.
Islet Transplantation Restores Blood Sugar Awareness and Control in Type 1 Diabetes—April 18, 2016
Bulletin: NIH Publishes Criteria for Research on Organ Transplantation Between People with HIV Infection—Nov. 25, 2015
Gene Variant Linked to Risk of Graft-Versus-Host Disease—Sept. 11, 2015
Stem Cell Transplants May Halt Progression of Multiple Sclerosis—Dec. 29, 2014
All Transplantation News Releases
News From NIAID-Supported Institutions
Last Updated April 18, 2016